Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072 Sichuan, China.
Key Laboratory of Chinese Internal Medicine of Ministry of Education and Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China.
J Diabetes Res. 2021 Feb 5;2021:8891093. doi: 10.1155/2021/8891093. eCollection 2021.
Diabetic nephropathy (DN) is one of the most common complications of diabetes mellitus and is a major cause of end-stage kidney disease. Cordyceps sinensis (Cordyceps, Dong Chong Xia Cao) is a widely applied ingredient for treating patients with DN in China, while the molecular mechanisms remain unclear. This study is aimed at revealing the therapeutic mechanisms of Cordyceps in DN by undertaking a network pharmacology analysis.
In this study, active ingredients and associated target proteins of Cordyceps sinensis were obtained via Traditional Chinese Medicine Systems Pharmacology Database (TCMSP) and Swiss Target Prediction platform, then reconfirmed by using PubChem databases. The collection of DN-related target genes was based on DisGeNET and GeneCards databases. A DN-Cordyceps common target interaction network was carried out via the STRING database, and the results were integrated and visualized by utilizing Cytoscape software. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed to determine the molecular mechanisms and therapeutic effects of Cordyceps on the treatment of DN.
Seven active ingredients were screened from Cordyceps, 293 putative target genes were identified, and 85 overlapping targets matched with DN were considered potential therapeutic targets, such as TNF, MAPK1, EGFR, ACE, and CASP3. The results of GO and KEGG analyses revealed that hub targets mainly participated in the AGE-RAGE signaling pathway in diabetic complications, TNF signaling pathway, PI3K-Akt signaling pathway, and IL-17 signaling pathway. These targets were correlated with inflammatory response, apoptosis, oxidative stress, insulin resistance, and other biological processes.
Our study showed that Cordyceps is characterized as multicomponent, multitarget, and multichannel. Cordyceps may play a crucial role in the treatment of DN by targeting TNF, MAPK1, EGFR, ACE, and CASP3 signaling and involved in the inflammatory response, apoptosis, oxidative stress, and insulin resistance.
糖尿病肾病(DN)是糖尿病最常见的并发症之一,也是终末期肾病的主要原因。冬虫夏草(Cordyceps,冬虫草)是中国治疗 DN 患者的常用药物,但具体的分子机制尚不清楚。本研究通过网络药理学分析揭示了冬虫夏草治疗 DN 的作用机制。
本研究通过中药系统药理学数据库(TCMSP)和瑞士靶点预测平台获取冬虫夏草的活性成分及其相关作用靶点,然后通过 PubChem 数据库进行再次确认。DN 相关靶点基因的收集基于 DisGeNET 和 GeneCards 数据库。通过 STRING 数据库构建 DN-冬虫夏草共同作用靶点网络,使用 Cytoscape 软件进行整合和可视化。通过基因本体论(GO)和京都基因与基因组百科全书(KEGG)通路富集分析确定冬虫夏草治疗 DN 的分子机制和治疗效果。
从冬虫夏草中筛选出 7 种活性成分,鉴定出 293 个潜在作用靶点,其中 85 个与 DN 重叠的靶点被认为是潜在的治疗靶点,如 TNF、MAPK1、EGFR、ACE 和 CASP3。GO 和 KEGG 分析结果表明,枢纽靶点主要参与糖尿病并发症的 AGE-RAGE 信号通路、TNF 信号通路、PI3K-Akt 信号通路和 IL-17 信号通路。这些靶点与炎症反应、细胞凋亡、氧化应激、胰岛素抵抗等生物学过程有关。
本研究表明,冬虫夏草具有多成分、多靶点、多途径的特点。冬虫夏草可能通过靶向 TNF、MAPK1、EGFR、ACE 和 CASP3 信号通路,参与炎症反应、细胞凋亡、氧化应激和胰岛素抵抗等生物学过程,在治疗 DN 中发挥重要作用。